Determining appropriate market valuations could help investors understand how expensive stocks could get or how deeply they ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $20.59, ...

The results from Goldman Sachs send a two-way message: one may act as a warning for stocks, while the other presents a potential opportunity instead. When it comes to the investment banking business ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $19.2, a high estimate of $25.00, and a low estimate of $16.00. A decline of 1.54% from the prior average ...

Waaree Energies sold a 2.4% stake in Indosolar via OFS. But is it just SEBI compliance or a signal for deeper capital and ...

In this piece, we will look at the stocks Jim Cramer recently discussed.

The market expects First Citizens BancShares (FCNCA) to deliver a year-over-year decline in earnings on lower revenues when ...

Q2 2025 saw a reversal of many first quarter factor trends. After lagging steeply in several regions in Q1, Momentum ...

Select Medical remains a soft 'buy' amid organic growth and solid performance, despite risks like Medicaid changes and recent ...

Chevron (CVX) gets the green light to move forward with its $53 billion acquisition of Hess (HES), after an arbitration panel ...

Strong customer activity in a challenging marketRevenue improved during the quarter while the market remains characterized by uncertainty, with a risk of delayed orders as a result. We continue to see ...